secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAIA Biotechnology, Inc. (MAIA)
CIK:        0001878313
Form:       8-K
Filed at:   2024-03-13T23:59:59+00:00
Accession:  0001193125-24-066954
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MAIA Biotechnology raises ~$2.92M in private placement of common stock and warrants
--------------------------------------------------------------------------------

- Sold 2,043,587 shares and warrants to accredited investors at $1.17/share for ~$2.4M gross.
- Directors purchased 452,731 shares and warrants at same price, raising ~$530,000.
- Warrants exercisable at $1.30 per share, beginning 6 months after issuance, 5-year term.
- Net proceeds to fund first third of pivotal THIO-101 trial Part C in NSCLC.
- Closing expected March 14, 2024; securities are restricted, no registration rights.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1878313/000119312524066954/0001193125-24-066954-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1878313/000119312524066954/d778616d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-066954

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer